Claes-Göran Löfdahl
41 – 50 of 147
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma
- Contribution to journal › Article
-
Mark
Symbicort SMART - Effective treatment at a lower cost
- Contribution to journal › Published meeting abstract
-
Mark
Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD
- Contribution to journal › Article
-
Mark
COPD and co-morbidities, with special emphasis on cardiovascular conditions
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Increased Prevalence of Multiple Sclerosis Among COPD Patients and Their First-Degree Relatives: A Population-based Study.
- Contribution to journal › Article
-
Mark
Specific nasal symptoms and symptom-provoking factors may predict increased risk of developing COPD.
- Contribution to journal › Article
- 2007
-
Mark
Mortality risks among heavy-smokers with special reference to women: a long-term follow-up of an urban population
- Contribution to journal › Article
-
Mark
Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD.
- Contribution to journal › Article
-
Mark
Protein Expression Patterns Associated with Progression of Chronic Obstructive Pulmonary Disease in Bronchoalveolar Lavage of Smokers.
- Contribution to journal › Article
-
Mark
Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma
- Contribution to journal › Article